Shoshanna Fischhoff

Researchers found that certain types of neurons were affected earlier in the disease, while others were affected later, offering significant new therapeutic targets.

NEUROdiab recognizes the basic science contributions of Mohamed Noureldein, Ph.D., to the field of diabetic neuropathy.

In the article "Skip That, Do This: Tips for Protecting Your Brain," Eva L. Feldman, M.D., Ph.D., talks about what do do and not do for brain health.

The American Neurological Association honored Eva L. Feldman, M.D., Ph.D., with an Awardfor Excellence.

In honor of Brain and Alzheimer’s Awareness Month, as well as the research made possible by the Wolfe Brain Health Initiative, Eva L. Feldman, M.D., Ph.D., shares how to protect and promote brain health.

Dr. Eva L. Feldman was featured on WWJ to speak about Michigan implementing mandatory reporting for ALS cases.

The State of Michigan has become the fifth state to establish a mandatory reporting rule for ALS cases due to the efforts of the ALS Center of Excellence, which could prove to be a catalyst for ALS research and prevention.

Despite progress in national leadership positions and independent funding, women still lag behind men in achieving top academic ranks and leadership roles in academic medicine.

Eva L. Feldman sat down with NeurRA Magazine for thier winter issue.

A new study points to a connection between cyanobacterial blooms and ALS survival.

Eva L. Feldman, M.D., Ph.D., talks about how ALS cases are on the rise and the importance of making it a reported disease.

Dr. Feldman talks about the importance of increasing awareness for ALS reporting.

Researchers looked at how diabetes and metabolic syndrome affected pain, neuropathy severity and fiber type.

We are sharing a roundup of our latest ALS publications in honor of ALS Awareness Month.

Findings from this study provide an important new therapy target in ALS.